QA: Biospecifics Technologies CORP in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000875622_2013_Biospecifics_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000875622, Biospecifics Technologies CORP

  xvar xval
0 AssetsCurrent 13,875,801
1 IntangibleAssetsNetIncludingGoodwill 280,322
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 4,234,141
4 LiabilitiesCurrent 724,528
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,774,828
9 ResearchAndDevelopmentExpense 1,249,755
10 remainder_Expenses 2,174,054
11 remainder_Revenues 11,145,078
12 remainder_NetIncome 34,634
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 18,390,264
1 Liabilities 724,528
2 Expenses 8,198,637
3 Revenues 11,145,078
4 StockholdersEquity 17,665,736
5 NetIncome 2,981,075
6 ComprehensiveNetIncome 2,981,075
7 BaseVar 19,246,570
8 EconomicCapitalRatiobeforeLimitedLiability 4.34
9 EconomicCapitalRatio 4.65

Edgar->Model Mapping

Feature Distribution

Change over Time